Microvast (MVST) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for October 23, 2025, to be held virtually, with voting rights extended to shareholders of record as of August 26, 2025.
Shareholders will vote on the election of one Class I director and the ratification of Deloitte as the independent auditor for fiscal 2025.
The board currently consists of five directors, following a reduction from seven, and is divided into three classes with staggered terms.
Proxy materials are primarily distributed electronically, with options for shareholders to vote online, by mail, or during the virtual meeting.
Voting matters and shareholder proposals
Proposal 1: Election of Wei Ying as Class I director for a three-year term.
Proposal 2: Ratification of Deloitte Touche Tohmatsu as independent auditor for fiscal 2025.
Board recommends voting FOR both proposals.
Shareholders may submit proposals for the 2026 meeting by April 27, 2026, for inclusion in the proxy statement.
Board of directors and corporate governance
Board consists of five directors: Yang Wu (Chair/CEO), Isida Tushe (President/GC), Arthur Wong, Yixin Pan, and Wei Ying.
Three directors (Pan, Ying, Wong) are independent per Nasdaq rules.
Board committees: Audit, Compensation, and Nominating & Corporate Governance, all with independent members.
Annual board and committee self-assessments are conducted.
Corporate governance guidelines and code of ethics are in place and available online.
Latest events from Microvast
- Q2 revenue up 12% to $83.7M, EMEA surged, but net loss widened on impairment and liquidity risks.MVST
Q2 20241 Feb 2026 - Q3 profit and 27% revenue growth driven by EMEA, but liquidity and expansion risks persist.MVST
Q3 202414 Jan 2026 - Record revenue, margin gains, and $401M backlog support strong 2025 growth outlook.MVST
Q4 202426 Dec 2025 - Offering up to $250M in securities to support growth in U.S. battery technology and production.MVST
Registration Filing16 Dec 2025 - Up to $250M in securities offered; major stockholder may sell 5.5M shares; broad risk factors disclosed.MVST
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify auditor, and address governance and compliance.MVST
Proxy Filing1 Dec 2025 - Virtual annual meeting to elect directors and ratify Deloitte as auditor for 2024.MVST
Proxy Filing1 Dec 2025 - Record Q1 revenue and profit, strong outlook, but liquidity and litigation risks persist.MVST
Q1 202525 Nov 2025 - Record Q2 revenue, margin gains, and positive adjusted EBITDA despite a large net loss.MVST
Q2 202523 Nov 2025